
Current Price | $22.28 | Mkt Cap | $2.2B |
---|---|---|---|
Open | $22.19 | P/E Ratio | -23.76 |
Prev. Close | $22.28 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $21.80 - $22.55 | Volume | 1,674,828 |
52-Wk Range | $2.02 - $25.72 | Avg. Daily Vol. | 4,861,386 |
Current Price | $22.28 | Mkt Cap | $2.2B |
---|---|---|---|
Open | $22.19 | P/E Ratio | -23.76 |
Prev. Close | $22.28 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $21.80 - $22.55 | Volume | 1,674,828 |
52-Wk Range | $2.02 - $25.72 | Avg. Daily Vol. | 4,861,386 |
The best Bull and Bear pitches based on recency and number of recommendations.
Can go up easily 10X if good results in NASH. Same MOA as MDGL.
Read the most recent pitches from players about VKTX.
Recs
Why Viking Therapeutics Stock Is Soaring Today
Motley Fool
George Budwell, The Motley Fool
,Motley Fool•September 18, 2018
What happened
Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biotech, saw its shares rise by as much as 180% in premarket trading today. The spark?
Viking's shares are soaring in response to a positive mid-stage result for its experimental nonalcoholic steatohepatitis (NASH) medicine VK2809. Most critically, the drug seems to compare favorably to Madrigal Pharmaceuticals' (NASDAQ: MDGL) MGL-3196 in terms of both safety and efficacy.
As a reminder, Madrigal's shares exploded higher earlier this year after reporting mid-stage results for MGL-3196. So, not surprisingly, Madrigal's shares sank by a staggering 14% in pre-market trading on the news that a major rival might have a more potent drug in development.
Recs
new drugs and emerging NASH market
Recs
long!
Find the members with the highest scoring picks in VKTX.
Under5 (59.76) Score: +1,785.33
The Score Leader is the player with the highest score across all their picks in VKTX.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
![]() |
Under5 | 59.76 |
|
![]() |
5Y | $1.12 | +1,883.93% | +72.71% | +1,811.22 | 3 Comments |
![]() |
skyrocket29 | 67.29 | 7/24/2017 |
![]() |
1Y | $1.16 | +1,815.52% | +73.81% | +1,741.70 | 0 Comment |
Corona20 | 39.75 | 5/24/2022 |
![]() |
5Y | $2.17 | +923.96% | +9.99% | +913.97 | 0 Comment | |
![]() |
GoldMiner20 | < 20 | 4/26/2022 |
![]() |
5Y | $2.32 | +857.76% | +1.96% | +855.79 | 0 Comment |
Playa14 | < 20 | 5/18/2022 |
![]() |
5Y | $2.38 | +833.61% | +6.13% | +827.48 | 0 Comment | |
![]() |
usubanas | 97.53 |
|
![]() |
5Y | $2.85 | +679.65% | +62.78% | +616.87 | 4 Comments |
Playa17 | < 20 | 9/12/2022 |
![]() |
5Y | $3.15 | +605.40% | +4.76% | +600.63 | 0 Comment | |
icewater3 | 68.78 | 1/28/2022 |
![]() |
3M | $3.45 | +544.06% | -1.04% | +545.10 | 0 Comment | |
degaston | 90.01 | 10/19/2022 |
![]() |
5Y | $4.02 | +452.74% | +16.06% | +436.68 | 0 Comment | |
shonny2 | 31.73 | 1/7/2022 |
![]() |
5Y | $4.31 | +415.55% | -8.48% | +424.03 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.